Analytical Data
-
基因名
SLAMF8
- Application
-
别名
SLAMF8；BLAME；SLAM family member 8
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9P0V8
-
表达区间
1-285aa
-
氨基酸序列
MVMRPLWSLLLWEALLPITVTGAQVLSKVGGSVLLVAARPPGFQVREAIWRSLWPSEELLATFFRGSLETLYHSRFLGRAQLHSNLSLELGPLESGDSGNFSVLMVDTRGQPWTQTLQLKVYDAVPRPVVQVFIAVERDAQPSKTCQVFLSCWAPNISEITYSWRRETTMDFGMEPHSLFTDGQVLSISLGPGDRDVAYSCIVSNPVSWDLATVTPWDSCHHEAAPGKASYKDVLLVVVPVSLLLMLVTLFSAWHWCPCSGKKKKDVHADRVGPETENPLVQDLP
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLAMF8 (Signaling Lymphocytic Activation Molecule Family Member 8) is a member of the SLAM family, which plays a critical role in immune responses, particularly in the modulation of T cell functions. Research has shown that SLAMF8 is involved in various immune-related processes, including the regulation of cytokine production and the enhancement of T cell activation and proliferation. Given its potential implications in autoimmune diseases and cancer immunity, the study of SLAMF8 has garnered significant attention in immunology. Recombinant SLAMF8 protein has been produced for in-depth studies to elucidate its structure, function, and signaling pathways. By investigating the interactions between SLAMF8 and other immune receptors, researchers aim to better understand its role in immune regulation and its potential as a therapeutic target. The development of SLAMF8 as a recombinant protein also provides a valuable tool for therapeutic applications and the design of novel immunomodulatory strategies. Furthermore, understanding SLAMF8's mechanisms could lead to advancements in treatments for various diseases, enhancing the ability to manipulate immune responses in clinical settings.
